Zolpidem Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: IR: 5 mg, 10 mg; ER: 6.25 mg, 12.5 mg;
Reference Brands: Ambien®, Ambien CR®, Edluar®, Zolpimist®, Intermezzo®(US); Stilnoct®, Edluar®(EU)
Category:
Antipsychotropic Drugs
Zolpidem, available as 5 mg, 10 mg, and extended-release tablets, is used to treat insomnia. Brands include Ambien®, Stilnoct®, and Edluar®. Pharma B2B suppliers provide Zolpidem in bulk from FDA/EU GMP-certified manufacturers, ensuring high-quality, regulatory-compliant sourcing for global pharmaceutical distributors and healthcare networks.
Zolpidem is available in Tablets
and strengths such as IR: 5 mg, 10 mg; ER: 6.25 mg, 12.5 mg;.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Zolpidem is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Zolpidem can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Zolpidem is a non-benzodiazepine sedative-hypnotic used for the short-term treatment of insomnia. It is available in multiple forms including immediate-release tablets (5 mg, 10 mg), extended-release tablets (6.25 mg, 12.5 mg), sublingual tablets, and oral spray. Leading brands include Ambien®, Ambien CR®, Stilnoct®, Edluar®, and Intermezzo®. Widely prescribed in the US and EU, Zolpidem enhances GABA activity to promote sleep onset and maintenance. Pharma B2B platforms offer bulk procurement of Zolpidem from GMP and US FDA/EU-compliant manufacturers, ensuring quality, regulatory adherence, and global distribution capabilities for hospitals, wholesalers, and sleep disorder treatment providers.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing